South African Propolis: Anti‐ Helicobacter pylori Activity, Chemistry, and Toxicity
Chemistry & Biodiversity · 2025-08 · 22 (8)
DOI: 10.1002/cbdv.202403200 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025-04. Verfasst von Sarhana Dinat und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy and Pharmacology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. Hauptthemen laut MEDLINE: Propolis, Helicobacter pylori, Anti-Bacterial Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NRF Thuthuka Fund, National Research Foundation, South African Medical Research Council.
Abstract (Originalsprache)
Propolis, a resin‐like substance produced by bees, has previously shown antimicrobial activity against the ulcer‐causing gut pathogen Helicobacter pylori . South African propolis, however, was yet to be investigated. This study aimed to investigate a comprehensive range of South African propolis for its antimicrobial activity against H. pylori and to investigate toxicity. A total of 51 samples were collected from around South Africa and comparatively analysed with three Brazilian samples. The antimicrobial broth microdilution assay was used to determine the minimum inhibitory concentration (MIC) of ethanolic propolis extracts against three clinical H. pylori strains. A total of 27 South African propolis extracts presented antimicrobial activity better than that of the Brazilian samples (MIC ≤ 0.51 mg/mL). Samples with the best anti‐ H. pylori activity were selected for chemical analysis using ultra‐performance liquid chromatography–mass spectrometry. The compounds pinocembrin, 3‐ O ‐acetylpinobanksin, and pinobanksin were found to be the most abundant. All propolis extracts investigated in this study were considered non‐toxic (mortality < 50%) when investigated using the brine shrimp lethality assay. This study demonstrates the in vitro potential of utilizing propolis for treating H. pylori infections and highlights the possible compounds responsible for the activity observed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy and Pharmacology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
- Department of Pharmaceutical Sciences, Faculty of Sciences, Tshwane University of Technology, Pretoria, South Africa.
- SAMRC Herbal Drugs Research Unit, Department of Pharmaceutical Sciences, Tshwane University of Technology, Pretoria, South Africa.
ORCID-Profile: Sarhana Dinat, Ané Orchard, Efficient Ncube, Alvaro Viljoen, Sandy van Vuuren
Förderung
- NRF Thuthuka Fund
- National Research Foundation
- South African Medical Research Council
- Faculty of Research Committee Individual Research Grant
Zitieren
APA
Dinat, S., Orchard, A., Ncube, E., Chen, W., Viljoen, A., & van Vuuren, S. (2025). South African Propolis: Anti‐ Helicobacter pylori Activity, Chemistry, and Toxicity. Chemistry & Biodiversity, 22(8). https://doi.org/10.1002/cbdv.202403200
Vancouver
Dinat S, Orchard A, Ncube E, Chen W, Viljoen A, van Vuuren S. South African Propolis: Anti‐ Helicobacter pylori Activity, Chemistry, and Toxicity. Chemistry & Biodiversity. 2025;22(8). doi:10.1002/cbdv.202403200
BibTeX
@article{Dinat2025,
author = {Dinat, Sarhana and Orchard, Ané and Ncube, Efficient and Chen, Weiyang and Viljoen, Alvaro and van Vuuren, Sandy},
title = {South African Propolis: Anti‐ Helicobacter pylori Activity, Chemistry, and Toxicity},
journal = {Chemistry & Biodiversity},
year = {2025},
volume = {22},
number = {8},
doi = {10.1002/cbdv.202403200}
}
EUVIMED